Vol 12, Supp. B (2017)
Praca na konkurs pt. "Terapia skojarzona"
Published online: 2018-03-04
Influence of non-classical cardiovascular risk factors on the choice of hypotensive and lipid-lowering therapy
DOI: 10.5603/FC.2017.0041
Abstract
Cardiovascular risk assessment in clinical practice isessential. It affects treatment methods of cardiovascular diseases
in patients. Recommended tools such as POL-SCORE do not take into account the clinical picture of all the patients.
The clinical case shows that the use of nonclassical elements of risk factors in clinical practice changes the scheme of
action undertaken so far.
Keywords: cardiovascular riskhypertensiondyslipidemia
References
- Piepoli MF, Hoes AW, Agewall S, et al. Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–2381.
- Tykarski A, Narkiewicz K, Gaciong Z. Zasady postępowania w nadciśnieniu tętniczym — 2015 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Arterial Hypertens. 2015; 19: 53–58.
- Zdrojewski T, Jankowski P, Bandosz P, et al. [A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol. 2015; 73(10): 958–961.
- Platek AE, Szymanski FM, Filipiak KJ, et al. Prevalence of depressive disorders in professional drivers — epidemiologic subanalysis of the RACER study. Psychiatr Pol. 2016; 50(4): 859–871.
- Niiranen TJ, Vasan RS. Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches. Expert Rev Cardiovasc Ther. 2016; 14(7): 855–869.
